基本信息
浏览量:310
职业迁徙
个人简介
His research interested is new drug R&D of Diabetes, cardiovascular, kidney disease. Since 2000, His research projects have been funded by National Major Science and Technology Program “new drug creation”, “863” Program, the National Basic Research Program of China (973 Program) and National Natural Science Foundation of China. He has made an impressive achievement in anti-diabetic, anti-cardiovascular diseases, anti-polycystic kidney drug discovery. He has published more than 100 original papers (cited more than 1000 times) such as PNAS、JACS etc. He also has applied 32 patents (authorized 20 international patents).His diabetic project has been transferred to international pharmaceutical company, and the kidney project has been transferred to domestic pharmaceutical company. His research results won the National Natural Science Awards (2nd class) in 2007 and Shanghai Science & Technology Progress Award (1st class) in 2003, Shanghai first-class technical professionals.
研究兴趣
论文共 267 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Acta Pharmacologica Sinicano. 8 (2023): 1649-1664
bioRxiv (Cold Spring Harbor Laboratory) (2023)
引用0浏览0引用
0
0
Natureno. 7979 (2023): 635-641
Journal of medicinal chemistryno. 12 (2023): 7988-8010
Zhaoxiang Song,Dan Lu,Jun Sun,Yangliang Ye,Jiahui Fang,Kai Wang,Shimeng Guo,Qing Zhang,Xinheng He,Xin Xie,Jianhua Shen
Bioorganic & medicinal chemistry (2023): 117511-117511
European Journal of Pharmacology (2023): 175812-175812
2022 3rd Information Communication Technologies Conference (ICTC)pp.56-60, (2022)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn